Last reviewed · How we verify

NCT04767100: DOMIROB

Study of the Impact of a Social Telepresence Robot on Social Isolation and Loneliness of the Elderly at Home

Completed Last updated 3 February 2023
What this trial tests

trial testing Social telepresence robot in Elderly People Living at Home in 56 participants. Completed in 29 July 2021.

Timeline
24 September 2020
Primary endpoint
8 July 2021
29 July 2021

Quick facts

Lead sponsorGérond'if
StatusCompleted
Study typeOBSERVATIONAL
Enrollment56
Start date24 September 2020
Primary completion8 July 2021
Estimated completion29 July 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Gérond'if — full company profile →

Who can join

65 and older, any sex, with Elderly People Living at Home or With an Internet Connection at Home. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this monocentric, prospective study is to measure the impact of the implementation of a robotic social telepresence tool, during three months at home, on the feeling of loneliness and social isolation of the elderly

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Telepresence Robot Intervention to Reduce Loneliness and Social Isolation in Older Adults Living at Home (Project DOMIROB): Protocol for a Clinical Nonrandomized Study.
    Isabet B, Rigaud AS, Li W, Pino M. · · 2022 · PMID 36315231 · DOI 10.2196/40528

Verify or expand the search:

Other Gérond'if trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04767100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing